You just read:

Diroximel Fumarate Demonstrated Significantly Improved Gastrointestinal Tolerability Profile Compared to Dimethyl Fumarate in Patients with Multiple Sclerosis

News provided by

Alkermes plc

Jul 30, 2019, 07:30 ET